Your Lymphoma Questions Answered: A Live Session with Dr. Joanna Rhodes image

Your Lymphoma Questions Answered: A Live Session with Dr. Joanna Rhodes

Can't make it to the event?
We send a recording to all registered participants of the event!
Oct 23, 2026
11:30AM - 12:30PM EDT
Online Event
Overview

Join us for a live Q&A with lymphoma expert Dr. Joanna Rhodes. Whether you’re newly diagnosed or a long-term survivor, this open forum is an opportunity to ask your questions and hear directly from a lymphoma expert. Bring the questions that are on your mind and gain practical insights to help you navigate your lymphoma journey.

SUBMIT YOUR QUESTIONS HERE!

Agenda
11:30 AM
Introduction
Hannah Loosle

Hannah introduces the agenda of the event and our guest speaker Dr. Joanna Rhodes

11:35 AM
Questions and Answers
Joanna Rhodes, MD

Come with your questions and Dr. Joanna Rhodes will answer them! 

Speakers & Moderators
Healthtree contact Hannah Loosle

Hannah Loosle

Hannah joined HealthTree Foundation as the Lymphoma Education Manager in 2024. She is a Certified Health Education Specialist and is passionate about helping patients feel empowered through education and connection. Before joining HealthTree, Hannah worked in healthcare policy helping patients advocate for better care, research, and funding.
Healthtree contact Joanna Rhodes, MD

Joanna Rhodes, MD

Dr. Joanna M. Rhodes is the Director of the Lymphoma Program at Rutgers Cancer Institute, Systems Lead for Lymphoma for RWJ Barnabas, and an Assistant Professor at the Rutgers New Jersey Medical School. She completed her medical degree at Stony Brook University School of Medicine and went on to complete her residency in Internal Medicine at New York Presbyterian- Weill Cornell. She did her fellowship at the University of Pennsylvania and also received a Master of Science in Clinical Epidemiology. She is board certified in Internal Medicine, hematology and medical oncology. Her clinical interests are in chronic lymphocytic leukemia and other lymphomas. Her research interests include the development of novel therapies for CLL and lymphomas as well as the pharmacoepidemiology of targeted agents in lymphoma and toxicity management strategies.